Hepion Pharma (HEPA) Stock Price, Quote, News & History

Hepion Pharmaceuticals Inc (HEPA) Stock Price, Quote, News & History

HEPAOTCQB

Trade with Public

$0.3180

At close: May 27, 5:00 PM EST

$0.0900

-0.23-71.70%

After Hours: Mar 10, 8:00 AM EST

Key Statistics

Open

Volume / Avg.

5.96K / 14.49K

Day Range

- - -

52 Wk Range

0.03 - 0.75

Market Cap

$1.05M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Hepion Pharmaceuticals Inc News

Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Fatty-Liver Focused Hepion Pharmaceuticals Agrees To Merge With Israel-Based Parkinson's Disease Drug Developer

Hepion Pharmaceuticals announces merger with Pharma Two B Ltd., creating a combined company focused on Parkinson's disease treatment. The merger values Hepion at $58.5 million, and Pharma Two B plans to list on Nasdaq under "PHTB".

Vandana Singh

Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?

Updates on Hepion Pharmaceuticals' ASCEND-NASH Trial, now in wind-down phase. Explore insights into Phase 2b study progression and strategic alternatives.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-3.27M

Investing Cash Flow (TTM)

-132.12K

Financing Cash Flow (TTM)

4.83M

Free Cash Flow (TTM)

-3.27M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

1.42M

Valuation Metrics

Enterprise Value

$439.63K

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

0.45

Earnings Yield % (TTM)

-2315.79%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.08

Company Debt

Total Debt

$54.07K

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$3.37M

Total Cash

$1.83M

Debt to Equity

0.06

Issuance of Debt (TTM)

-$3.37M

Repayment of Debt (TTM)

-$3.37M

Key Statistics

Open

Volume / Avg.

5.96K / 14.49K

Day Range

- - -

52 Wk Range

0.03 - 0.75

Market Cap

$1.05M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development of drug therapy for the treatment of chronic liver diseases. The company is pioneering early cancer detection solutions with a novel liquid biopsy. diagnostics....

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Hepion Pharma (HEPA) stock?

You can purchase shares of Hepion Pharma (OTCQB:HEPA) through any online brokerage.

View our list of the best stock brokerages

Who are Hepion Pharma (HEPA) competitors?

There are no as such competitors for Hepion Pharma.

What is the forecast, or price target, for Hepion Pharma (HEPA) stock?

There is no analysis for Hepion Pharma to provide a consensus price target.

What is the current price for Hepion Pharma (HEPA)?

The stock price for Hepion Pharma (OTCQB: HEPA) is $0.09 last updated March 10, 2026 at 8:00 AM EDT.

Does Hepion Pharma (HEPA) pay a dividend?

There are no upcoming dividends for Hepion Pharma.

When is Hepion Pharma (OTCQB:HEPA) reporting earnings?

Hepion Pharma does not have any upcoming earnings scheduled.

Is Hepion Pharma (HEPA) going to split?

There is no upcoming split for Hepion Pharma.

What sector and industry does Hepion Pharma (HEPA) operate in?

Hepion Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.

Key Statistics

Open

Volume / Avg.

5.96K / 14.49K

Day Range

- - -

52 Wk Range

0.03 - 0.75

Market Cap

$1.05M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Hepion Pharmaceuticals Inc News

Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Fatty-Liver Focused Hepion Pharmaceuticals Agrees To Merge With Israel-Based Parkinson's Disease Drug Developer

Vandana Singh

Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?

Updates on Hepion Pharmaceuticals' ASCEND-NASH Trial, now in wind-down phase. Explore insights into Phase 2b study progression and strategic alternatives.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-3.27M

Investing Cash Flow (TTM)

-132.12K

Financing Cash Flow (TTM)

4.83M

Free Cash Flow (TTM)

-3.27M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

1.42M

Valuation Metrics

Enterprise Value

$439.63K

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

0.45

Earnings Yield % (TTM)

-2315.79%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.08

Company Debt

Total Debt

$54.07K

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$3.37M

Total Cash

$1.83M

Debt to Equity

0.06

Issuance of Debt (TTM)

-$3.37M

Repayment of Debt (TTM)

-$3.37M

Key Statistics

Open

Volume / Avg.

5.96K / 14.49K

Day Range

- - -

52 Wk Range

0.03 - 0.75

Market Cap

$1.05M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Hepion Pharma (HEPA) stock?

You can purchase shares of Hepion Pharma (OTCQB:HEPA) through any online brokerage.

View our list of the best stock brokerages

Who are Hepion Pharma (HEPA) competitors?

There are no as such competitors for Hepion Pharma.

What is the forecast, or price target, for Hepion Pharma (HEPA) stock?

There is no analysis for Hepion Pharma to provide a consensus price target.

What is the current price for Hepion Pharma (HEPA)?

The stock price for Hepion Pharma (OTCQB: HEPA) is $0.09 last updated March 10, 2026 at 8:00 AM EDT.

Does Hepion Pharma (HEPA) pay a dividend?

There are no upcoming dividends for Hepion Pharma.

When is Hepion Pharma (OTCQB:HEPA) reporting earnings?

Hepion Pharma does not have any upcoming earnings scheduled.

Is Hepion Pharma (HEPA) going to split?

There is no upcoming split for Hepion Pharma.

What sector and industry does Hepion Pharma (HEPA) operate in?

Hepion Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.